(Alliance News) - AstraZeneca PLC on Monday said its lupus drug Saphnelo received a positive opinion from the European Medicines Agency's committee for medicinal products for human use for a new subcutaneous formulation. Read More
(Alliance News) - B&M European Value Retail cuts its profit guidance following an accounting error and says Chief Financial Officer Mike Schmidt will step down, while Bank of Ireland and Secure Trust Bank may increase provisions linked to the UK motor finance redress scheme. AstraZeneca announces a drug approval in the US. Read More
(Alliance News) - Daiichi Sankyo Co Ltd on Sunday reported promising clinical activity across multiple oncology programmes, including early signals in solid tumours and new data in breast cancer. Read More
(Alliance News) - Amgen Inc and AstraZeneca on Friday said the US Food & Drug Administration had broadened the indication for Tezspire to a second disease. Read More
(Alliance News) - AstraZeneca PLC on Friday said Saphnelo subcutaneous self-administration has been recommended for approval in the European Union for systemic lupus erythematosus. Read More
(Alliance News) - Astrazeneca PLC on Friday said that adding its Imfinzi drug to the treatment of bladder cancer was linked to lower mortality rates. Read More
(Alliance News) - Stock prices in Europe traded sharply lower on Friday, with sentiment souring at the end of the week, and declines on the FTSE 100 were largely broad-based. Read More
(Alliance News) - Stocks in London struggled on the back of a tepid UK gross domestic product reading, but peers in Europe made strides and equities in New York are set to open higher. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More
(Alliance News) - Federal Reserve rate cut expectations lifted stock market sentiment on Wednesday, but the FTSE 100 missed out on the rally, as some of its heavyweights traded lower. Read More
(Alliance News) - The FTSE 100 recouped some of Friday's hefty losses, while gold soared once more, as Donald Trump dialled down his rhetoric in the trade spat between the US and China. Read More
(Alliance News) - AstraZeneca PLC on Monday confirmed it has reached a "historic" drug pricing agreement with the Donald Trump administration in the US. Read More
(Alliance News) - Lender Lloyds Banking Group has set aside another GBP800 million related to motor finance matters, Oxford Instruments reports a tariff hit first half and Serica Energy has agreed a deal with BP to acquire North Sea assets. Read More
(Alliance News) - US President Donald Trump announced a deal with AstraZeneca PLC on Friday that he said would lead to significantly lower domestic drug prices in exchange for granting the pharma giant tariff relief. Read More
(Alliance News) - President Donald Trump on Friday plans to announce an agreement with the pharmaceuticals firm AstraZeneca PLC to lower drug prices in the US, MSNBC reported, citing a White House official. Read More
(Alliance News) - AstraZeneca PLC on Thursday said it will increase investment at its new Virginia manufacturing facility by USD500 million, bringing its total pledge to USD4.5 billion. Read More
(Alliance News) - AstraZeneca PLC on Tuesday said its therapy for hypertension demonstrated positive results in a recent phase 3 trial, while its breast cancer therapy is put forward for review in Japan. Read More
(Alliance News) - Stock prices in London were mostly lower at midday on Monday, while data published by S&P Global showed that the UK construction sector's decline slowed in September. Read More
(Alliance News) - AstraZeneca PLC has signed a USD555 million deal with San Francisco-based Algen Biotechnologies to develop gene-editing therapies using artificial intelligence, the Financial Times reported on Monday. Read More
(Alliance News) - Stock prices in London opened mostly lower on Monday, while in the Middle East ceasefire talks are due to start between Israel and Hamas. Read More